Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2022
Facts and Hopes in the Relationship of EBV with Cancer Immunity and ImmunotherapyBaochun Zhang, Il-Kyu ChoiTrends in Immunology|October 10, 2022
Does delayed EBV infection contribute to rising childhood cancers?Baochun Zhang, Il-Kyu Choi, Jutatip Panaampon, et al.BMB Reports|March 2, 2023
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunitySeongmin Jeong, Nawon Jang, Minchae Kim, et al.Oncotarget|December 22, 2016
Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor modelEonju Oh, Il-Kyu Choi, JinWoo Hong, et al.Clinical and Experimental Vaccine Research|August 5, 2017
Animal models for dengue vaccine development and testingWoonsung Na, Minjoo Yeom, Il-Kyu Choi, et al.Plos One|July 12, 2013
Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunityIl-Kyu Choi, Yan Li, Eonju Oh, et al.Frontiers in Oncology|July 31, 2013
Strategies to increase drug penetration in solid tumorsIl-Kyu Choi, Robert Strauss, Maximilian Richter, et al.Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|December 13, 2012
A novel three-dimensional model system for keloid study: organotypic multicellular scar modelWon Jai Lee, Il-Kyu Choi, Ju Hee Lee, et al.Mathematical Biosciences and Engineering : MBE|May 15, 2015
Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeuticsPeter S Kim, Joseph J Crivelli, Il-Kyu Choi, et al.Human Gene Therapy|January 18, 2012
Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapyTaeyoung Koo, Il-Kyu Choi, Minjung Kim, et al.Pageof 3